ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 61 filers reported holding ONCOCYTE CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $352,000 | -82.1% | 162,300 | -70.7% | 0.00% | -75.0% |
| Q3 2021 | $1,970,000 | -36.1% | 553,324 | +3.0% | 0.00% | -42.9% |
| Q2 2021 | $3,083,000 | +40.9% | 537,121 | +27.4% | 0.01% | +16.7% |
| Q1 2021 | $2,188,000 | +504.4% | 421,542 | +122.3% | 0.01% | +200.0% |
| Q2 2020 | $362,000 | +1031.2% | 189,649 | +1358.8% | 0.00% | – |
| Q1 2020 | $32,000 | -27.3% | 13,000 | -37.8% | 0.00% | – |
| Q3 2019 | $44,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,596,680 | $16,725,000 | 2.33% |
| Artal Group S.A. | 150,000 | $698,000 | 0.01% |
| Destination Wealth Management | 29,656 | $138,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $674,000 | 0.01% |
| IHT Wealth Management, LLC | 563 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 695 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 44,048 | $205,000 | 0.00% |
| Vantage Investment Advisors, LLC | 25 | $0 | 0.00% |
| UBS Group AG | 5,204 | $24,000 | 0.00% |
| Legal & General Group Plc | 384 | $2,000 | 0.00% |